These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1174 related items for PubMed ID: 19628647

  • 1. Randomized controlled clinical trial of corticosteroids plus ACE-inhibitors with long-term follow-up in proteinuric IgA nephropathy.
    Manno C, Torres DD, Rossini M, Pesce F, Schena FP.
    Nephrol Dial Transplant; 2009 Dec; 24(12):3694-701. PubMed ID: 19628647
    [Abstract] [Full Text] [Related]

  • 2. Prospective randomized controlled multicenter trial on steroids plus ramipril in proteinuric IgA nephropathy.
    Manno C, Gesualdo L, D'Altri C, Rossini M, Grandaliano G, Schena FP.
    J Nephrol; 2001 Dec; 14(4):248-52. PubMed ID: 11506246
    [Abstract] [Full Text] [Related]

  • 3. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial.
    Lv J, Zhang H, Chen Y, Li G, Jiang L, Singh AK, Wang H.
    Am J Kidney Dis; 2009 Jan; 53(1):26-32. PubMed ID: 18930568
    [Abstract] [Full Text] [Related]

  • 4. IgACE: a placebo-controlled, randomized trial of angiotensin-converting enzyme inhibitors in children and young people with IgA nephropathy and moderate proteinuria.
    Coppo R, Peruzzi L, Amore A, Piccoli A, Cochat P, Stone R, Kirschstein M, Linné T.
    J Am Soc Nephrol; 2007 Jun; 18(6):1880-8. PubMed ID: 17513327
    [Abstract] [Full Text] [Related]

  • 5. IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.
    Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.
    J Nephrol; 2013 Jun; 26(1):86-93. PubMed ID: 22460183
    [Abstract] [Full Text] [Related]

  • 6. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 Jun; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 7. Fractional urinary excretion of IgG is the most powerful predictor of renoprotection by ACE inhibitors in IgA nephropathy.
    Bazzi C, Rizza V, Paparella M, Casellato D, Napodano P, Olivieri G, D'Amico G.
    J Nephrol; 2009 Jun; 22(3):387-96. PubMed ID: 19557716
    [Abstract] [Full Text] [Related]

  • 8. Hong Kong study using valsartan in IgA nephropathy (HKVIN): a double-blind, randomized, placebo-controlled study.
    Li PK, Leung CB, Chow KM, Cheng YL, Fung SK, Mak SK, Tang AW, Wong TY, Yung CY, Yung JC, Yu AW, Szeto CC, HKVIN Study Group.
    Am J Kidney Dis; 2006 May; 47(5):751-60. PubMed ID: 16632013
    [Abstract] [Full Text] [Related]

  • 9. [Immunosuppressive therapy in IgA glomerulonephritis with chronic renal failure: case study presentation and literature review].
    Pozzi C, Del Vecchio L, Locatelli F.
    G Ital Nefrol; 2002 May; 19(5):523-8. PubMed ID: 12439840
    [Abstract] [Full Text] [Related]

  • 10. [Treatment of IgA nephropathy with chronic renal failure].
    Pozzi C.
    G Ital Nefrol; 2008 May; 25 Suppl 44():83-7. PubMed ID: 19048591
    [Abstract] [Full Text] [Related]

  • 11. Long-term renal survival and related risk factors in patients with IgA nephropathy: results from a cohort of 1155 cases in a Chinese adult population.
    Le W, Liang S, Hu Y, Deng K, Bao H, Zeng C, Liu Z.
    Nephrol Dial Transplant; 2012 Apr; 27(4):1479-85. PubMed ID: 21965586
    [Abstract] [Full Text] [Related]

  • 12. Diuretic uptitration with half dose combined ACEI + ARB better decreases proteinuria than combined ACEI + ARB uptitration.
    Esnault VL, Ekhlas A, Nguyen JM, Moranne O.
    Nephrol Dial Transplant; 2010 Jul; 25(7):2218-24. PubMed ID: 20106824
    [Abstract] [Full Text] [Related]

  • 13. Strict blood-pressure control and progression of renal failure in children.
    ESCAPE Trial Group, Wühl E, Trivelli A, Picca S, Litwin M, Peco-Antic A, Zurowska A, Testa S, Jankauskiene A, Emre S, Caldas-Afonso A, Anarat A, Niaudet P, Mir S, Bakkaloglu A, Enke B, Montini G, Wingen AM, Sallay P, Jeck N, Berg U, Caliskan S, Wygoda S, Hohbach-Hohenfellner K, Dusek J, Urasinski T, Arbeiter K, Neuhaus T, Gellermann J, Drozdz D, Fischbach M, Möller K, Wigger M, Peruzzi L, Mehls O, Schaefer F.
    N Engl J Med; 2009 Oct 22; 361(17):1639-50. PubMed ID: 19846849
    [Abstract] [Full Text] [Related]

  • 14. Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia).
    Lancet; 1997 Jun 28; 349(9069):1857-63. PubMed ID: 9217756
    [Abstract] [Full Text] [Related]

  • 15. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR, Kong NC, Gafor AH, Rahman AF, Zainuddin S, Mustaffa WM, Radzi AM, Shamsul AS.
    Singapore Med J; 2008 Nov 28; 49(11):924-9. PubMed ID: 19037561
    [Abstract] [Full Text] [Related]

  • 16. Predictors for progression in immunoglobulin A nephropathy with significant proteinuria.
    Hwang HS, Kim BS, Shin YS, Yoon HE, Song JC, Choi BS, Park CW, Yang CW, Kim YS, Bang BK.
    Nephrology (Carlton); 2010 Mar 28; 15(2):236-41. PubMed ID: 20470285
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.
    Am J Kidney Dis; 2008 Sep 28; 52(3):475-85. PubMed ID: 18468748
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of corticosteroid therapy on the progression of IgA nephropathy with moderate proteinuria.
    Uzu T, Harada T, Ko M, Yamato M, Takahara K, Yamauchi A.
    Clin Exp Nephrol; 2003 Sep 28; 7(3):210-4. PubMed ID: 14586717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.